|
|
|||
| |||||||||||||||||||||||||||||||||||||||||||
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.
In February 2007, fever developed in a previously healthy 15-year-old girl, with a peak temperature of 102°F (38.9°C) and mild upper respiratory congestion. The next day she was seen by her primary care physician. A rapid screening test for group A streptococcus was negative, and oseltamivir was prescribed. After two doses, she continued to have fever and also had nausea and emesis,
The Clinical Problem
Strategies and Evidence
Priorities for Vaccination
Composition and Distribution of Influenza Vaccine
Efficacy of the Vaccine
Case Management
Who Should Be Treated?
Antiviral Treatments
Areas of Uncertainty
Guidelines
Conclusions and Recommendations
Source Information
From the Departments of Molecular Virology and Microbiology and of Pediatrics, Baylor College of Medicine, Houston.
An audio version of this article is available at www.nejm.org.
Address reprint requests to Dr. Glezen at the Departments of Molecular Virology and Microbiology and of Pediatrics, Baylor College of Medicine, 1 Baylor Plaza, MS:BCM-280, Houston, TX 77030, or at wglezen@bcm.edu.
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |